Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Osteosarcoma and ERCC5[original query] |
|---|
| Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. The pharmacogenomics journal 2009 Oct 9 (5): 347-53. Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira |
| Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors. Asian Pacific journal of cancer prevention : APJCP 2013 14 (3): 2049-52. Sun Xiao-Hui, Hou Wen-Gen, Zhao Hong-Xing, Zhao Yi-Lei, Ma Chao, Liu Yi |
| ERCC polymorphisms and prognosis of patients with osteosarcoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Oct 35 (10): 10129-36. Li Jinsong, Liu Shaohua, Wang Weiguo, Zhang Kexiang, Liu Zhendong, Zhang Chaoyue, Chen Shijie, Wu So |
| Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. International journal of clinical and experimental pathology 2015 8 (7): 7905-12. Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi |
| Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 11652-7. Wang M J, Zhu Y, Guo X J, Tian Z |
| Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis. OncoTargets and therapy 2018 11 3495-3504. Li Chunpu, Yu Xin, Guo Dongmei, Liu Guanhua, Zhang Kaigang, Teng Qingliang, Lin H |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: